GENE EXPRESSION AND IMMUNOGENS OF UROEPITHELIAL TUMORS

Information

• Research Project
• 6075914

• ApplicationId

  6075914

• Core Project Number

  R43CA080440

• Full Project Number

  1R43CA080440-01A2

• Serial Number

  80440

• FOA Number

• Sub Project Id

• Project Start Date

  2/1/2000 - 24 years ago

• Project End Date

  1/31/2001 - 23 years ago

• Program Officer Name

  MUSZYNSKI, KAREN

• Budget Start Date

  2/1/2000 - 24 years ago

• Budget End Date

  1/31/2001 - 23 years ago

• Fiscal Year

  2000

• Support Year

  1

• Suffix

  A2

• Award Notice Date

  1/27/2000 - 24 years ago

Organizations

• Vaccinex, Inc.

Genes differentially expressed in human bladder tumors will be identified. Expression of these gene products in multiple independently derived bladder tumors and diverse normal tissues will be characterized. This study will focus on those gene products recurrently expressed in different tumors but either not expressed or expressed at significantly reduced levels in normal tissues. Full length cDNA corresponding to the selected genes will be isolated and the immunogenicity of these gene products will be evaluated for use as vaccines for bladder cancer. PROPOSED COMMERCIAL APPLICATIONS: This research is directed at developing vaccines for prevention and therapy of bladder cancer.

IC Name

• Activity

  R43

• Administering IC

  CA

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  100000

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:100000\

• Funding Mechanism

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  VACCINEX, INC.

• Organization Department

• Organization DUNS

• Organization City

  ROCHESTER

• Organization State

  NY

• Organization Country

  UNITED STATES

• Organization Zip Code

  14620

• Organization District

  UNITED STATES